Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.28 EUR | -3.45% |
|
-9.53% | -28.21% |
04/04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
09/02 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.21% | 1.29Cr | |
+38.36% | 5.27TCr | |
+39.33% | 3.9TCr | |
-8.63% | 3.85TCr | |
+25.46% | 3.04TCr | |
-11.17% | 2.64TCr | |
+11.44% | 2.61TCr | |
+45.09% | 1.42TCr | |
+32.93% | 1.26TCr | |
-5.30% | 1.15TCr |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Celyad Oncology in Breach of Nasdaq's Listing Rule